Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting1
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%

Trials by Status

active_not_recruiting133%
completed133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruiting

Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran

NCT05873868
unknown

Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions

NCT05661071
completed

Long Term Outcomes of Coronavirus Disease-19 (COVID-19)

NCT04715919

Clinical Trials (3)

Showing 3 of 3 trials
NCT05873868

Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran

Active Not Recruiting
NCT05661071

Neuropsychological Profiles of Children With Duchenne Muscular Dystrophy and Its Effects on Motor Functions

Unknown
NCT04715919

Long Term Outcomes of Coronavirus Disease-19 (COVID-19)

Completed

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3